Parkinson's Disease

Featured Article
Does MCI Influence Anxiety, Cognitive Performance in PD?
Researchers analyzed the association between cognitive performance and psychiatric symptoms among individuals with PD, and they found that those with PD and anxiety may be more likely to experience worse executive functioning if they have mild cognitive impairment.
Apomorphine Sublingual Film Reduces Off Episodes in Parkinson's Disease
"The availability of this new apomorphine sublingual formulation, along with an inhaled formulation under development, will broaden the treatment options for off periods," says Angelo Antonini, MD,…
Deep Brain Stimulation for Parkinson's Might Disrupt Swimming Ability
Researchers found that some people lose their ability to swim when their Parkinson disease is treated with deep brain stimulation.

Newsfeed

Does MCI Influence Anxiety, Cognitive Performance in PD?
Apomorphine Sublingual Film Reduces Off Episodes in Parkinson's Disease
Deep Brain Stimulation for Parkinson's Might Disrupt Swimming Ability
Aerobic Exercise May Relieve Motor Symptoms in Patients With Parkinson Disease
Better Sleep Means Better Early-Morning Mobility in Parkinson's Disease
Exercise Boosts Ventral Striatum Activity, Caudate Dopamine Release in PD
Music Enhances Control in Adults With PD
Yoga Improves Balance, Eases Back Pain in Parkinson Disease
View More

Insights

Clinical Distinctions Between US Nursing Home Residents With Parkinson Disease With and Without Parkinson Disease Psychosis
This retrospective database analysis evaluated the demographic, functional, and clinical characteristics of nursing facility residents (NFR) with Parkinson disease (PD) compared with those with PD psychosis.
A Potential Blood Test for Parkinson Disease
Despite Parkinson disease diagnosis challenges, new research shines light on a potential noninvasive diagnostic test. Professor of neurology at the Brain Research Institute Gal Bitan, PhD, discusses his recent study findings.
Determining Appropriate Time to Initiate PD Treatment
Rob di Bie, MD, PhD, neurologist and professor of Movement Disorders at the University of Amsterdam’s Faculty of Medicine, discusses the long-term effects of a specific PD medication and the impact of starting the drug early.
View More

Interactive Features

Is it Safe to Treat PD With a Drug Approved for Psuedobulbar Affect?
Michael Fralick, MD, FRCPC, Brigham and Women’s Hospital, discusses his recent study that examined a medication approved for psuedobulbar affect, which he found was regularly being prescribed to patients with PD and dementia. He explains why these…
View More
Back to Top